Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Letter to the Editor

Volume 6, Number 5, October 2014, pages 392-394


Potential Biomarker for Human Uterine Leiomyosarcoma

Figure

Figure 1.
Figure 1. Summary of IHC experiments for p53, LMP2, cyclin B, calponin h1 and ki-67 expression levels in leiomyoma (LMA) and leiomyosarcoma (LMS). IHC experiments were performed using seven LMA tissue samples and 23 LMS tissue samples obtained from patients with LMA and/or LMS. Data were quantified using WinROOF Ver.6.3.0 software (Mitani Co., Ltd, Fukui, Japan). P vales were generated using a t-test. Data are representative of three experiments. +++: diffuse-positive (homogeneous distribution with more than 90% of cells stained), -: negative (no stained cells).